Skip to main content
. 2022 Sep 8;8(11):1579–1587. doi: 10.1001/jamaoncol.2022.3846

Figure 1. Flowchart Depicting Samples Drawn and Successfully Analyzed From Patients and Controls.

Figure 1.

aA total of 144 controls were excluded because their matched cases had too low DNA concentration.

bFive cases had triple-negative breast cancer (TNBC) and high-grade serous ovarian cancer (HGSOC) and were included as cases in the hazard ratio estimates for TNBC and HGSOC.

cA total of 1272 controls were included as controls in the hazard ratio estimates for TNBC and HGSOC.